TABLE 1.
Demographic data and clinical characteristics at baseline
| Atorvastatin (n=327) | Control (n=321) | P | |
|---|---|---|---|
| Emergent PCI | 60 | 75 | 0.122 |
| Type I diabetes | 116 | 128 | 0.257 |
| OMI | 144 | 132 | 0.465 |
| Revascularization | 44 | 60 | 0.086 |
| Number of diseased vessels | 690 | 715 | |
| 1 | 108 | 88 | |
| 2 | 75 | 72 | 0.224 |
| 3 | 144 | 161 | |
| Lesion type (AHA/ACC) | 725 | 757 | |
| A/B1 | 105 | 138 | |
| B2 | 288 | 271 | 0.096 |
| C | 332 | 348 | |
| Stent | |||
| Cypher (Cordis, USA) | 30 | 39 | |
| Taxus (Boston Scientific, USA) | 22 | 33 | 0.991 |
| Bare metal | 275 | 249 | |
| Baseline lipid concentration | |||
| TC (mmol/L) | 5.85±1.29 | 5.72±1.27 | 0.186 |
| TG (mmol/L) | 3.33±0.76 | 3.44±0.66 | 0.091 |
| ApoA (g/L) | 1.38±0.17 | 1.36±0.11 | 0.063 |
| ApoB (g/L) | 1.04±0.26 | 1.02±0.22 | 0.264 |
| HDL-C (mmol/L) | 1.40±0.29 | 1.39±0.28 | 0.461 |
| LDL-C (mmol/L) | 3.21±0.65 | 3.29±0.69 | 0.129 |
AHA/ACC American Heart Association/American College of Cardiology; ApoA Apolipoprotein A; ApoB Apolipoprotein B; HDL-C High-density lipoprotein cholesterol; LDL-C Low-density lipoprotein cholesterol; OMI Old myocardial infarction; PCI Percutaneous coronary intervention; TC Total cholesterol; TG Triglyeride